Gryphon Financial Partners LLC Incyte Corp Transaction History

Gryphon Financial Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 06, 2018	SELL	$61.75 - $74.23 $741 - $890	-12 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$60.85 - $83.98 $3,103 - $4,282	-51 Reduced 80.95%	12 $0
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $3,156 - $3,837	38 Added 152.0%	63 $5,000
Q4 2017 Feb 09, 2018	BUY	$93.56 - $116.6 $2,339 - $2,915	25	25 $3,000

644

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Gryphon Financial Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Gryphon Financial Partners LLC with notifications on news.